文献速递临床试验与 GCP流行病学与生物统计

面向纵向终点的贝叶斯II期概念验证临床试验设计

A Bayesian phase II proof-of-concept design for clinical trials with longitudinal endpoints.
PubMed 文献 · Stat Med · 2023-11-08

针对现有II期试验设计仅关注单一标量终点的局限,本文提出一种面向纵向测量终点的贝叶斯II期设计。该设计采用贝叶斯分层模型和惩罚样条建模个体与群体轨迹,以曲线下面积汇总随时间变化的治疗效果,结合成组序贯方法与贝叶斯准则,同时考量统计学显著性与临床相关性,模拟研究显示该设计稳健且运行特征良好。

要点

  • 提出面向纵向终点的贝叶斯II期设计,以轨迹曲线下面积汇总随时间变化的治疗效果。
  • 采用贝叶斯分层模型与惩罚样条,无需对轨迹形状作强参数假设。
  • 采用成组序贯方法与贝叶斯准则,中期和最终决策同时考量统计学显著性与临床相关性。

核心结论

  • 模拟研究显示所提出的设计稳健,具有理想的运行特征。

研究设计与样本

  • 提出一种贝叶斯II期临床试验设计,适用于疗效终点为纵向测量的试验。
  • 采用贝叶斯分层模型建模纵向测量过程,个体轨迹向群体轨迹收缩以借用个体间信息。
  • 采用贝叶斯惩罚样条建模个体和群体轨迹,不对轨迹形状作强参数假设。
  • 以轨迹的曲线下面积作为治疗效果随时间的汇总指标。
  • 采用成组序贯方法,并提出贝叶斯准则基于统计学显著性和临床相关性证据作出中期和最终决策。

主要发现

  • 模拟研究显示所提出的设计稳健,具有理想的运行特征。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Existing phase II clinical trial designs focus on a single scalar endpoint, such as a binary, continuous, or survival endpoint. In some clinical trials, such as pain management studies, the efficacy endpoint of interest is measured longitudinally. We propose a Bayesian phase II design for such clinical trials. We model the longitudinal measurement process using Bayesian hierarchical model, where subject-specific trajectory shrinks toward the population trajectory to borrow information across subjects. The Bayesian penalized spline is used to model subject-specific and population trajectories without making strong parametric assumption on their shapes. We use the area under the curve of the trajectory as the summary of the treatment effect over time. The design takes a group sequential approach and takes into account both statistical significance and clinical relevance. Bayesian criteria is proposed to make interim and final decisions based on the evidence of statistical significance and clinical relevance. The proposed design is highly flexible and can accommodate trials with one or multiple longitudinal endpoints, as well as a longitudinal primary endpoint with a secondary endpoint. Simulation study shows that the proposed design is robust with desirable operating characteristics.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Zhang W, Laird G, Chen J, et al. A Bayesian phase II proof-of-concept design for clinical trials with longitudinal endpoints. Stat Med. 2023. PMID: 37937591. doi:10.1002/sim.9948

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。